![Andrea Pfeifer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrea Pfeifer
Fondateur chez AC IMMUNE SA
Fortune : 10 M $ au 30/06/2024
Postes actifs de Andrea Pfeifer
Sociétés | Poste | Début | Fin |
---|---|---|---|
AC IMMUNE SA | Directeur/Membre du Conseil | 01/01/2016 | - |
Directeur Général | 13/02/2003 | - | |
Fondateur | 13/02/2003 | - | |
Investor Relations Contact | 13/02/2003 | - | |
SYMRISE AG | Directeur/Membre du Conseil | 01/05/2011 | - |
Independent Dir/Board Member | 01/05/2011 | - | |
University of Lausanne | Corporate Officer/Principal | - | - |
BioMedInvest AG I
![]() BioMedInvest AG I Investment ManagersFinance BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million. | Président | - | - |
AB2 Bio SA
![]() AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Président | - | - |
Historique de carrière de Andrea Pfeifer
Anciens postes connus de Andrea Pfeifer
Sociétés | Poste | Début | Fin |
---|---|---|---|
2INVEST AG | Directeur/Membre du Conseil | 27/05/2010 | 18/10/2012 |
Nestlé Nespresso SA
![]() Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Nestlé Nespresso SA designs and manufactures espresso machines. The company was founded in 1986 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | 01/01/1998 | - |
Inventages II
![]() Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Fondateur | - | - |
BioMedPartners AG
![]() BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Président | 29/08/2002 | - |
░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Andrea Pfeifer
Wuerzburg Schweinfurt University of Applied Sciences | Doctorate Degree |
Statistiques
Internationale
Suisse | 8 |
Allemagne | 4 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Chairman | 3 |
Sectorielle
Finance | 5 |
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
AC IMMUNE SA | Health Technology |
2INVEST AG | Finance |
SYMRISE AG | Process Industries |
Entreprise privées | 6 |
---|---|
Nestlé USA, Inc.
![]() Nestlé USA, Inc. Agricultural Commodities/MillingProcess Industries Nestle USA, Inc. produces dairy and bakery products. Its products include chocolate and confectionaries, beverages, ice cream, juices, milk products, pet food, prepared foods, and sports nutrition. The company is headquartered in Arlington, VA. | Process Industries |
BioMedPartners AG
![]() BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Finance |
BioMedInvest AG I
![]() BioMedInvest AG I Investment ManagersFinance BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million. | Finance |
AB2 Bio SA
![]() AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Health Technology |
Inventages II
![]() Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Finance |
Nestlé Nespresso SA
![]() Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Nestlé Nespresso SA designs and manufactures espresso machines. The company was founded in 1986 and is headquartered in Zurich, Switzerland. | Producer Manufacturing |
- Bourse
- Insiders
- Andrea Pfeifer
- Expérience